Terms: = Sarcomas AND LYL1, P12980, 4066, ENSG00000104903 AND Treatment
3 results:
1. Outcome of rare primary malignant bone sarcoma treated with multimodal therapy: Results from the EUROpean Bone Over 40 Sarcoma Study (EURO-B.O.S.S.).
Palmerini E; Reichardt P; Hall KS; Bertulli R; Bielack SS; Comandone A; Egerer G; Hansmeier A; Kevric M; Carretta E; Hansson L; Jebsen N; Eriksson M; Bruland ØS; Donati DM; Ibrahim T; Smeland S; Ferrari S
Cancer; 2023 Nov; 129(22):3564-3573. PubMed ID: 37530385
[TBL] [Abstract] [Full Text] [Related]
2. Clinical evaluation of continuous daily dosing of sunitinib malate in patients with advanced gastrointestinal stromal tumour after imatinib failure.
George S; Blay JY; Casali PG; Le Cesne A; Stephenson P; Deprimo SE; Harmon CS; Law CN; Morgan JA; Ray-Coquard I; Tassell V; Cohen DP; Demetri GD
Eur J Cancer; 2009 Jul; 45(11):1959-68. PubMed ID: 19282169
[TBL] [Abstract] [Full Text] [Related]
3. High complication rate of reconstruction using Ilizarov bone transport method in patients with bone sarcomas.
Ozaki T; Nakatsuka Y; Kunisada T; Kawai A; Dan'ura T; Naito N; Inoue H
Arch Orthop Trauma Surg; 1998; 118(3):136-9. PubMed ID: 9932187
[TBL] [Abstract] [Full Text] [Related]
